| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,776 |
10,215 |
$1.56M |
| G0378 |
Hospital observation service, per hour |
3,172 |
1,580 |
$1.08M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,540 |
4,046 |
$871K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,701 |
2,871 |
$701K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,056 |
2,307 |
$426K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,640 |
2,523 |
$301K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,332 |
7,288 |
$265K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,208 |
3,570 |
$245K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,957 |
1,349 |
$242K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,591 |
1,658 |
$219K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,494 |
918 |
$204K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,250 |
1,917 |
$170K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,254 |
1,512 |
$166K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,604 |
2,079 |
$160K |
| 71045 |
Radiologic examination, chest; single view |
3,836 |
2,844 |
$120K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,762 |
2,323 |
$108K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,198 |
1,740 |
$108K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,244 |
2,597 |
$100K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,546 |
730 |
$95K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
359 |
321 |
$85K |
| 71046 |
Radiologic examination, chest; 2 views |
2,831 |
2,228 |
$85K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,929 |
2,896 |
$79K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,652 |
881 |
$72K |
| 80053 |
Comprehensive metabolic panel |
10,017 |
6,962 |
$69K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
405 |
322 |
$65K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,928 |
9,292 |
$64K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
746 |
557 |
$61K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,782 |
1,797 |
$57K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,867 |
2,123 |
$54K |
| 84484 |
|
3,137 |
2,066 |
$22K |
| 76801 |
|
290 |
251 |
$21K |
| 83880 |
|
957 |
709 |
$20K |
| 76818 |
|
281 |
108 |
$19K |
| 86900 |
|
338 |
236 |
$19K |
| 83874 |
|
2,726 |
1,789 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,229 |
2,255 |
$17K |
| 59025 |
Fetal non-stress test |
164 |
69 |
$17K |
| 82553 |
|
2,702 |
1,774 |
$16K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$16K |
| H0033 |
Oral medication administration, direct observation |
7,131 |
4,144 |
$16K |
| 87430 |
|
1,160 |
921 |
$14K |
| 97162 |
|
391 |
331 |
$13K |
| 81025 |
|
2,170 |
1,665 |
$12K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
90 |
37 |
$12K |
| 80305 |
|
1,810 |
1,317 |
$12K |
| 86756 |
|
756 |
612 |
$9K |
| 82948 |
|
2,827 |
955 |
$8K |
| 81001 |
|
4,410 |
3,137 |
$7K |
| 74018 |
|
160 |
127 |
$7K |
| 86738 |
|
712 |
547 |
$7K |
| 81000 |
|
3,125 |
2,120 |
$6K |
| 86901 |
|
376 |
263 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
87 |
78 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
112 |
90 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
45 |
40 |
$6K |
| 97016 |
|
632 |
142 |
$5K |
| 86850 |
|
152 |
77 |
$5K |
| 97014 |
|
976 |
177 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
501 |
145 |
$5K |
| 87088 |
|
973 |
751 |
$4K |
| 73630 |
|
122 |
92 |
$3K |
| G0379 |
Direct admission of patient for hospital observation care |
347 |
232 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,261 |
3,074 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
278 |
186 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
58 |
29 |
$3K |
| 83690 |
|
644 |
471 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,327 |
2,079 |
$2K |
| 87040 |
|
295 |
215 |
$2K |
| 81015 |
|
1,309 |
840 |
$2K |
| 83735 |
|
451 |
319 |
$2K |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
14 |
12 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,353 |
3,082 |
$2K |
| 73030 |
|
12 |
12 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,765 |
1,914 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
313 |
215 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,248 |
1,886 |
$1K |
| 36600 |
|
39 |
28 |
$1K |
| 82150 |
|
300 |
215 |
$1K |
| 85379 |
|
156 |
121 |
$834.58 |
| 74019 |
|
14 |
13 |
$813.53 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,333 |
1,326 |
$738.20 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
30 |
17 |
$638.40 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
188 |
126 |
$633.83 |
| 73560 |
|
19 |
12 |
$604.56 |
| 82077 |
|
52 |
33 |
$567.91 |
| 87077 |
|
82 |
69 |
$523.38 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
98 |
71 |
$458.95 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
993 |
512 |
$438.98 |
| 86140 |
|
130 |
104 |
$339.27 |
| 71250 |
|
18 |
12 |
$334.41 |
| 82803 |
|
38 |
27 |
$268.84 |
| 85027 |
|
49 |
39 |
$266.63 |
| 85610 |
|
110 |
82 |
$255.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
12 |
$254.84 |
| 87184 |
|
44 |
39 |
$232.32 |
| 80306 |
|
17 |
12 |
$185.16 |
| 85730 |
|
34 |
26 |
$131.34 |
| Q3014 |
Telehealth originating site facility fee |
24 |
14 |
$119.96 |
| 87070 |
|
12 |
12 |
$77.49 |
| 94664 |
|
1,374 |
957 |
$57.24 |
| 84550 |
|
14 |
14 |
$54.24 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
67 |
12 |
$52.80 |
| 87205 |
|
15 |
13 |
$51.36 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
31 |
27 |
$12.65 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,255 |
983 |
$1.65 |
| J7050 |
Infusion, normal saline solution, 250 cc |
264 |
148 |
$0.00 |
| 91301 |
|
329 |
328 |
$0.00 |
| 96376 |
|
511 |
194 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
115 |
48 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
44 |
25 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
61 |
53 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
82 |
48 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
33 |
26 |
$0.00 |
| 94760 |
|
21 |
12 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
286 |
223 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
71 |
51 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
462 |
280 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
40 |
32 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
23 |
13 |
$0.00 |